Literature DB >> 23041284

Reciprocal regulation of Akt and Oct4 promotes the self-renewal and survival of embryonal carcinoma cells.

Yuanji Lin1, Ying Yang, Weihua Li, Qi Chen, Jie Li, Xiao Pan, Lina Zhou, Changwei Liu, Chunsong Chen, Jianqin He, Hongcui Cao, Hangping Yao, Li Zheng, Xiaowei Xu, Zongping Xia, Jiangtao Ren, Lei Xiao, Lanjuan Li, Binghui Shen, Honglin Zhou, Ying-Jie Wang.   

Abstract

Signaling via the Akt serine/threonine protein kinase plays critical roles in the self-renewal of embryonic stem cells and their malignant counterpart, embryonal carcinoma cells (ECCs). Here we show that in ECCs, Akt phosphorylated the master pluripotency factor Oct4 at threonine 235, and that the levels of phosphorylated Oct4 in ECCs correlated with resistance to apoptosis and tumorigenic potential. Phosphorylation of Oct4 increased its stability and facilitated its nuclear localization and its interaction with Sox2, which promoted the transcription of the core stemness genes POU5F1 and NANOG. Furthermore, in ECCs, unphosphorylated Oct4 bound to the AKT1 promoter and repressed its transcription. Phosphorylation of Oct4 by Akt resulted in dissociation of Oct4 from the AKT1 promoter, which activated AKT1 transcription and promoted cell survival. Therefore, a site-specific, posttranslational modification of the Oct4 protein orchestrates the regulation of its stability, subcellular localization, and transcriptional activities, which collectively promotes the survival and tumorigenicity of ECCs.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23041284      PMCID: PMC3601782          DOI: 10.1016/j.molcel.2012.08.030

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  55 in total

Review 1.  The phosphatidylinositol 3-Kinase AKT pathway in human cancer.

Authors:  Igor Vivanco; Charles L Sawyers
Journal:  Nat Rev Cancer       Date:  2002-07       Impact factor: 60.716

Review 2.  Applying the principles of stem-cell biology to cancer.

Authors:  Ricardo Pardal; Michael F Clarke; Sean J Morrison
Journal:  Nat Rev Cancer       Date:  2003-12       Impact factor: 60.716

3.  HIF induces human embryonic stem cell markers in cancer cells.

Authors:  Julie Mathieu; Zhan Zhang; Wenyu Zhou; Amy J Wang; John M Heddleston; Claudia M A Pinna; Alexis Hubaud; Bradford Stadler; Michael Choi; Merav Bar; Muneesh Tewari; Alvin Liu; Robert Vessella; Robert Rostomily; Donald Born; Marshall Horwitz; Carol Ware; C Anthony Blau; Michele A Cleary; Jeremy N Rich; Hannele Ruohola-Baker
Journal:  Cancer Res       Date:  2011-06-28       Impact factor: 12.701

4.  Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells.

Authors:  H Niwa; J Miyazaki; A G Smith
Journal:  Nat Genet       Date:  2000-04       Impact factor: 38.330

5.  Pluripotency factors in embryonic stem cells regulate differentiation into germ layers.

Authors:  Matt Thomson; Siyuan John Liu; Ling-Nan Zou; Zack Smith; Alexander Meissner; Sharad Ramanathan
Journal:  Cell       Date:  2011-06-10       Impact factor: 41.582

Review 6.  Targeting the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin signaling network in cancer stem cells.

Authors:  A M Martelli; C Evangelisti; M Y Follo; G Ramazzotti; M Fini; R Giardino; L Manzoli; J A McCubrey; L Cocco
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

Review 7.  Control of the embryonic stem cell state.

Authors:  Richard A Young
Journal:  Cell       Date:  2011-03-18       Impact factor: 41.582

8.  Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation.

Authors:  Shih-Hwa Chiou; Mong-Lien Wang; Yu-Ting Chou; Chi-Jen Chen; Chun-Fu Hong; Wang-Ju Hsieh; Hsin-Tzu Chang; Ying-Shan Chen; Tzu-Wei Lin; Han-Sui Hsu; Cheng-Wen Wu
Journal:  Cancer Res       Date:  2010-12-15       Impact factor: 12.701

Review 9.  The transcriptional and signalling networks of pluripotency.

Authors:  Huck-Hui Ng; M Azim Surani
Journal:  Nat Cell Biol       Date:  2011-05       Impact factor: 28.824

10.  Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumors.

Authors:  Jamie M Sperger; Xin Chen; Jonathan S Draper; Jessica E Antosiewicz; Chris H Chon; Sunita B Jones; James D Brooks; Peter W Andrews; Patrick O Brown; James A Thomson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-31       Impact factor: 11.205

View more
  87 in total

1.  AKT-driven phospho-patterns of pluripotency.

Authors:  Thorsten Schaefer; Claudia Lengerke
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

2.  Akt Phosphorylates Wnt Coactivator and Chromatin Effector Pygo2 at Serine 48 to Antagonize Its Ubiquitin/Proteasome-mediated Degradation.

Authors:  Qiuling Li; Yuewei Li; Bingnan Gu; Lei Fang; Pengbo Zhou; Shilai Bao; Lan Huang; Xing Dai
Journal:  J Biol Chem       Date:  2015-07-13       Impact factor: 5.157

3.  Nuclear localized Akt enhances breast cancer stem-like cells through counter-regulation of p21(Waf1/Cip1) and p27(kip1).

Authors:  Mayur Vilas Jain; Jaganmohan R Jangamreddy; Jerzy Grabarek; Frank Schweizer; Thomas Klonisch; Artur Cieślar-Pobuda; Marek J Łos
Journal:  Cell Cycle       Date:  2015-06-01       Impact factor: 4.534

4.  Autophagic homeostasis is required for the pluripotency of cancer stem cells.

Authors:  Tanveer Sharif; Emma Martell; Cathleen Dai; Barry E Kennedy; Patrick Murphy; Derek R Clements; Youra Kim; Patrick W K Lee; Shashi A Gujar
Journal:  Autophagy       Date:  2016-12-08       Impact factor: 16.016

5.  Identification of a cell-of-origin for fibroblasts comprising the fibrotic reticulum in idiopathic pulmonary fibrosis.

Authors:  Hong Xia; Vidya Bodempudi; Alexey Benyumov; Polla Hergert; Damien Tank; Jeremy Herrera; Jeff Braziunas; Ola Larsson; Matthew Parker; Daniel Rossi; Karen Smith; Mark Peterson; Andrew Limper; Jose Jessurun; John Connett; David Ingbar; Sem Phan; Peter B Bitterman; Craig A Henke
Journal:  Am J Pathol       Date:  2014-03-13       Impact factor: 4.307

6.  Activation of D2 Dopamine Receptors in CD133+ve Cancer Stem Cells in Non-small Cell Lung Carcinoma Inhibits Proliferation, Clonogenic Ability, and Invasiveness of These Cells.

Authors:  Soumyabrata Roy; Kai Lu; Mukti Kant Nayak; Avishek Bhuniya; Tithi Ghosh; Suman Kundu; Sarbari Ghosh; Rathindranath Baral; Partha Sarathi Dasgupta; Sujit Basu
Journal:  J Biol Chem       Date:  2016-12-05       Impact factor: 5.157

7.  Novel AKT phosphorylation sites identified in the pluripotency factors OCT4, SOX2 and KLF4.

Authors:  Peter N Malak; Benjamin Dannenmann; Alexander Hirth; Oliver C Rothfuss; Klaus Schulze-Osthoff
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

8.  Site-specific Disruption of the Oct4/Sox2 Protein Interaction Reveals Coordinated Mesendodermal Differentiation and the Epithelial-Mesenchymal Transition.

Authors:  Xiao Pan; Xiaohui Cang; Songsong Dan; Jingchao Li; Jie Cheng; Bo Kang; Xiaotao Duan; Binghui Shen; Ying-Jie Wang
Journal:  J Biol Chem       Date:  2016-07-01       Impact factor: 5.157

9.  Frequent somatic mutations of the telomerase reverse transcriptase promoter in ovarian clear cell carcinoma but not in other major types of gynaecological malignancy.

Authors:  Ren-Chin Wu; Ayse Ayhan; Daichi Maeda; Kyu-Rae Kim; Blaise A Clarke; Patricia Shaw; Michael Herman Chui; Barry Rosen; Ie-Ming Shih; Tian-Li Wang
Journal:  J Pathol       Date:  2014-03       Impact factor: 7.996

10.  Multiple novel hepatocellular carcinoma signature genes are commonly controlled by the master pluripotency factor OCT4.

Authors:  Chao Ye; Xiaoqian Zhang; Xinyu Chen; Qingyi Cao; Xiaobing Zhang; Yanwen Zhou; Wenxin Li; Liangjie Hong; Haiyang Xie; Xiaoli Liu; Hongcui Cao; Ying-Jie Wang; Bo Kang
Journal:  Cell Oncol (Dordr)       Date:  2019-12-17       Impact factor: 6.730

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.